Pulmonx Corporation
LUNG
$7.05
-$0.27-3.69%
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | 22.01% | 22.34% | 26.26% | 27.14% | 27.98% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 22.01% | 22.34% | 26.26% | 27.14% | 27.98% |
| Cost of Revenue | 21.56% | 18.54% | 23.58% | 24.45% | 29.91% |
| Gross Profit | 22.16% | 23.72% | 27.22% | 28.10% | 27.31% |
| SG&A Expenses | 7.96% | 8.10% | 11.73% | 12.48% | 13.84% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 8.33% | 7.88% | 11.29% | 13.94% | 16.30% |
| Operating Income | 6.83% | 7.08% | 3.49% | -1.18% | -5.62% |
| Income Before Tax | 7.26% | 7.04% | 4.52% | 0.76% | -2.91% |
| Income Tax Expenses | -12.43% | 24.78% | 13.14% | 54.39% | 61.76% |
| Earnings from Continuing Operations | 7.31% | 6.75% | 4.37% | 0.38% | -3.26% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 7.31% | 6.75% | 4.37% | 0.38% | -3.26% |
| EBIT | 6.83% | 7.08% | 3.49% | -1.18% | -5.62% |
| EBITDA | 8.28% | 8.36% | 4.77% | -1.30% | -5.71% |
| EPS Basic | 10.02% | 9.36% | 6.90% | 2.78% | -0.90% |
| Normalized Basic EPS | 9.98% | 9.65% | 7.06% | 3.18% | -0.55% |
| EPS Diluted | 10.02% | 9.36% | 6.90% | 2.78% | -0.90% |
| Normalized Diluted EPS | 9.98% | 9.65% | 7.06% | 3.18% | -0.55% |
| Average Basic Shares Outstanding | 3.00% | 2.88% | 2.74% | 2.55% | 2.36% |
| Average Diluted Shares Outstanding | 3.00% | 2.88% | 2.74% | 2.55% | 2.36% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |
